Substance / Medication

Silver

Overview

Active Ingredient
silver
RxNorm CUI
2606543

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Exploring Green-Synthesized Silver Nanoparticles in Neurodegeneration: a Systematic Review of Cholinesterase Enzyme Interactions.
Ahamed Md Shobuj, Ahamed Ananna, Jim Jubayer Chakladar et al. · Mol Neurobiol · 2026
PMID: 41577863Meta-Analysis
Silver dressings for treating diabetic foot ulcers: a systematic review and meta-analysis.
Xie Qinci, Wang Jinying, Huang Gaofeng et al. · J Tissue Viability · 2025
PMID: 40997520Meta-Analysis
Systematic review of silver and vanadium-based antibiofilm agents: mechanisms and efficacy in oral biofilms.
Carvalho-Silva João Marcos, Dos Reis Andréa Cândido · Future Microbiol · 2025
PMID: 40545688Meta-AnalysisFull text (PMC)
Can the use of silver nanoparticles in dental implants increase its antimicrobial potency? - systematic review.
Joseph Brice, Sultan Nessma, Jayash Soher Nagi · BMC Oral Health · 2025
PMID: 40684101Meta-AnalysisFull text (PMC)
Silver sulfadiazine therapy for the management of burns.
Iswati Erinda Tri, Handayani Estrin, Subrata Sumarno Adi et al. · Br J Community Nurs · 2025
PMID: 40095932Meta-Analysis
Silver-based dressings for the prevention of surgical site infections: evidence from randomized trials.
Younes S, Younes N, Abunasser S et al. · J Hosp Infect · 2025
PMID: 40355088Meta-Analysis
Effects of silver diamine fluoride in human dentin: A systematic review of in vitro studies.
Amorim Andressa Cardoso, Carvalho Allyne Jorcelino Daloia de, Carvalho Mary Stefany Andrade et al. · Eur J Oral Sci · 2025
PMID: 40500138Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Specialists

Providers who commonly manage this intervention

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Silver (substance)
SNOMED CT
41967008
UMLS CUI
C0037125
RxNorm CUI
2606543

Clinical Data

This intervention maps to 6 entities in the Healos knowledge graph.

2
Conditions
2
Biomarkers
1
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.